No Data
No Data
Is Cogent Biosciences (NASDAQ:COGT) In A Good Position To Invest In Growth?
J.P. Morgan Maintains Cogent Biosciences(COGT.US) With Buy Rating, Raises Target Price to $23
Cogent Biosciences (COGT) Gets a Buy From J.P. Morgan
Express News | Cogent Biosciences Inc : JP Morgan Raises Target Price to $23 From $21
Needham Downgrades Cogent Biosciences to Hold, Maintains Price Target to $15
Express News | Cogent Biosciences Inc : Needham Cuts to Hold From Buy